Ropes & Gray advised Arbor Biotechnologies on the deal.Arbor Biotechnologies announced an oversubscribed and up-sized $215 million Series B financing. Arbor plans to use the funds…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
